Emergent BioSolutions to Webcast Its Participation at the 25th Annual Piper Jaffray Healthcare Conference
ROCKVILLE, Md.–(BUSINESS WIRE)–Nov. 20, 2013– Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will lead a discussion, which may involve recent business developments and financial results, at the 25th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, December 4, 2013 at 1:30 PM Eastern.
A webcast of the discussion will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com